Tracon Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tracon Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • Tracon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $339K, a 32.5% decline year-over-year.
  • Tracon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $1.71M, a 12.3% decline year-over-year.
  • Tracon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.97M, a 3.53% decline from 2022.
  • Tracon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.04M, a 15% increase from 2021.
  • Tracon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.78M, a 71.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.97M -$72K -3.53% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $2.04M +$266K +15% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $1.78M +$741K +71.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 $1.03M -$590K -36.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-08
2019 $1.62M -$1.04M -39.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 $2.67M -$527K -16.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $3.19M +$111K +3.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $3.08M +$995K +47.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $2.09M +$1.82M +670% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $271K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.